Please login to the form below
Gates Foundation
This page shows the latest Gates Foundation news and features for those working in and with pharma, biotech and healthcare.
WHO and global partners launch new effort to address falling childhood vaccination rates
WHO, UNICEF, Gavi, the Vaccine Alliance, the Bill &Melinda Gates Foundation and others announced 'The Big Catch-Up' to reverse the declines and protect populations from vaccine-preventable outbreaks such as
Latest news
-
Gates MRI and Calibr announce licensing agreement for tuberculosis treatment
The discovery and preclinical studies of Calibr’s CLB073 were done through a partnership for TB drug discovery and development funded by the Bill &Melinda Gates Foundation. ... Now, under the terms of the agreement, Gates MRI will be granted an
-
Act-Accelerator outlines plans for longterm COVID-19 control
Set up in 2020, ACT-A was launched by the World Health Organization (WHO), the President of France, the President of the European Commission and the Bill &Melinda Gates Foundation, in
-
Bill & Melinda Gates Foundation commit $1.2bn as part of efforts to end polio worldwide
The Bill &Melinda Gates Foundation (the Foundation) has revealed it will commit $1.2bn to bolster efforts to end all forms of polio worldwide. ... Commenting on the need for further action against polio, Bill Gates, co-chair of the Bill &Melinda Gates
-
Manus Bio awarded $2m by Bill & Melinda Gates Foundation to combat malaria
Manus Bio has received a fourth award of $2m from the Bill &Melinda Gates Foundation to accelerate the development of a scalable and cost-effective production route for artemisinin, a key ... Commenting on the additional funding, Dr Christine Santos,
-
New Pfizer initiative, ‘An Accord for a Healthier World’, launched to improve global health equity
With funding from the Bill &Melinda Gates Foundation, Pfizer is working to develop vaccine candidates for Group B Streptococcus, a leading cause of stillbirth and newborn mortality in low-income countries. ... Bill Gates, Co-Chair of the Bill &Melinda
More from news
Approximately 11 fully matching, plus 61 partially matching documents found.
Latest Intelligence
-
Tuberculosis – why it remains a major global public health challenge
The Bill &Melinda Gates Foundation funds much of the work of Gates MRI, and we serve as the product development organisation of the philanthropic body. ... Foundation. Under the agreement, Merck has granted Gates MRI an exclusive global licence for
-
Exploiting the value of data in pharma
The value of data collaboration. In March this year, the Bill &Melinda Gates Foundation launched an initiative called the COVID-19 Therapeutics Accelerator philanthropically bringing together a consortium of 15 of
-
Working together against COVID-19
Recently the Bill and Melinda Gates Foundation brought together an ‘unprecedented’ coronavirus partnership with the industry.
-
Pharma deals during May 2013
Another venture captial company, Novo A/S, the company that manages the $30bn assets of the Novo Nordisk Foundation, has also made a major deal with the $700m acquisition of the ... In Japan six local companies are contributing, along with the Bill and
-
Interview: Charles Mgone, EDCTP
In the case of HIV, we're working with IAVI [International AIDS Vaccine Initiative] and the Bill and Melinda Gates Foundation. ... For instance, with the Gates Foundation we put funds together to support capacity to conduct clinical trials.
More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.
Latest appointments
-
Syneos Health Communications announces senior hires to Europe-based team
She has previously led global campaigns for the World Health Organisation, The Global Fund, IFPMA, The Bill and Melinda Gates Foundation and the ABPI.
-
Dan Carucci becomes global chief medical officer of McCann Health
Previously, he was appointed as the first director of the Grand Challenges in Global Health Initiative, a programme for the Bill &Melinda Gates Foundation. ... In addition, as vice president of global health at the United Nations Foundation, Carucci has
-
Dr Keith Bragman joins Alacrita
Gates Foundation and at the UK government's department for international development.
-
Cello Health Insight bolsters senior team
She brings 13 years of experience in quantitative research to the role, and has spent the last few years focused on public sector market research for the Bill &Melinda Gates Foundation.
-
Gary Nabel to lead Sanofi's strategy council
He succeeds Dr Richard Klausner, a former executive director for Global Health of the Bill and Melinda Gates Foundation, who led the council since March 2011. ... His predecessor as SDSAC chair Dr Klausner, in addition to his work at the Bill and Melinda
More from appointments
Approximately 0 fully matching, plus 5 partially matching documents found.
Latest from PMHub
-
Maria Eletskaya joins Cello Health Insight
She is a trained psychologist and for the last years she has been focused on public sector market research for the Bill &Melinda Gates Foundation.
-
A better future, or too ambitious to be true?
With so many leading organisations involved, including the Bill and Melinda Gates Foundation, perhaps we just might.
More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.
Subscribe to our email news alerts
- Home Based Account Manager, Medical Communications, UK, Pharma/M...
- Highly competitive salary
- Market Access Director, six figure base salary and £5K joining b...
- Highly competitive salary
- Account Manager, 6 month contract, Healthcare Brand communicatio...
- Highly competitive salary
- Senior Medical Copywriter - Highly Awarded Advertising Agency
- £50,000 - £60,000 yearly
- Account Manager, Healthcare Marketing Creative Agency, Fixed ter...
- Highly competitive salary
- Account Director, Healthcare Marketing Creative Agency, Fixed te...
- Highly competitive salary
- Pfizer reports positive results for elranatamab in multiple myeloma
- BMS presents positive four-year results for Opdivo combination in lung cancer
- AstraZeneca to stop post-marketing study of Andexxa following early success
- Amgen’s Lumakras shows promise in phase 3 lung cancer study
- Novartis receives EC approval for Cosentyx in hidradenitis suppurativa
- Pfizer’s antibiotic combination shows promise in treating multi-drug resistant infections
- European Commission grants two new marketing authorisations for UCB's Bimzelx
- AstraZeneca/Sanofi’s RSV antibody backed by FDA advisory committee for infants
- Janssen shares positive phase 3 results for cilta-cel in multiple myeloma
- Parkinson’s disease: past, present and future
- How to Increase Engagement During Virtual Events
- AstraZeneca to stop post-marketing study of Andexxa following early success
No results were found
PMHub
Say Communications
We focus on what matters most…. Driven by insight, expertise and fresh thinking, our award-winning communications programmes are designed to...
Latest intelligence
- Parkinson’s disease: past, present and future
- Examining the history and complexities of Parkinson’s disease – one of the most prevalent neurodegenerative disorders that affects over 10 million people worldwide...
- The 17th World Congress on Controversies in Neurology
- This year, there was a focus on the rare disease neuromyelitis optica spectrum disorder that strikes suddenly and mainly impacts women...
- Archetypes: Rethinking go-to-market expectations to drive commercial success
- In this white paper, our consultants analyze trends spanning global policy developments, rising inflation, and increasingly complex customer journeys, and reveal a new data-driven approach to archetyping that crystalizes the...
